TPTX - Turning Point Therapeutics Inc. (TPTX) CEO Athena Countouriotis on Q3 2021 Results - Earnings Call Transcript
Turning Point Therapeutics, Inc. (TPTX) Q3 2021 Results Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Adam Levy - Senior Vice President of Investor Relations Athena Countouriotis - President and Chief Executive Officer Paolo Tombesi - Executive Vice President and Chief Financial Officer Conference Call Participants Paul Choi - Goldman Sachs Michael Schmidt - Guggenheim Securities Matt Biegler - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Andrew Berens - SVB Leerink Presentation Operator Good day. And thank you for standing by. Welcome to the Turning Point Therapeutics Third Quarter 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Adam Levy. Thank you. Please go ahead. Adam Levy Thank you, operator. Good afternoon, everyone. First, let me start by
For further details see:
Turning Point Therapeutics, Inc. (TPTX) CEO Athena Countouriotis on Q3 2021 Results - Earnings Call Transcript